FDA Inspection 1162063 — Agnieszka Ciesiolkiewicz-Wojcik, M.D.
The FDA completed an inspection of Agnieszka Ciesiolkiewicz-Wojcik, M.D. on January 21, 2022 in Wroclaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 21, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Wroclaw (Poland)
Additional Details
Clinical Investigator (CI)